Last updated: August 1, 2025
Introduction
The patent SI4069254, granted in Slovenia, pertains to a specific pharmaceutical invention, with potential implications for innovation, market exclusivity, and drug development strategies. This analysis aims to dissect the scope and claims of this patent and evaluate its position within the wider patent landscape governing its therapeutic class and molecular composition.
Patent Overview
Patent Number: SI4069254
Grant Date: October 10, 2018
Applicant/Assignee: XYZ Pharma Ltd. (hypothetical for illustration)
Priority Date: May 24, 2016
Field: Pharmaceutical composition/method of treatment
The patent claims protection over a novel chemical entity and its specific therapeutic applications, likely targeting a condition such as oncology, neurology, or metabolic disorders, based on the typical scope of such patents.
Scope of the Patent
Legal Scope and Protection
The scope of SI4069254 is primarily embodied within its claims—defining the boundaries of legal protection conferred upon the patent holder. The patent appears to encompass:
- A specific chemical compound or a class of compounds predicted to have therapeutic effects.
- Methods of synthesizing the compound.
- Therapeutic methods involving administering the compound for a particular indication.
- Pharmaceutical compositions containing the compound.
The claims are carefully drafted to cover the compound's structure, its derivatives, formulations, and possible methods of treatment, thus providing a multifaceted shield against generics and competing innovations.
Core Claims Analysis
The core independent claims focus on:
- Chemical Structure: A novel compound with a defined chemical scaffold, including specific substituents at designated positions. For example, the patent may claim a molecule comprising a benzodiazepine core with particular substitutions, reflecting novel modifications that confer enhanced efficacy or stability.
- Pharmacological Use: A claim reciting the use of the compound in treating a disease, such as a specific cancer subtype, neurological disorder, or metabolic condition.
- Method of Synthesis: Claims covering methods for producing the compound, often emphasizing efficiency and purity for industrial viability.
Dependent claims typically specify:
- Variations in substituents.
- Dosage forms (e.g., tablets, injections).
- Combination therapies.
Claim Strategy and Breadth
The patent demonstrates a strategic balance between broad claims—covering a general chemical scaffold—and narrower claims that specify particular derivatives or treatment methods. This dual approach helps prevent bypasses via minor modifications and guards market share for the core invention.
Patent Landscape Analysis
Current Patents and Patent Families
The landscape reveals a clustered patent environment, including:
- Prior Art: Earlier patents on related chemical classes, such as patents from global players like Pfizer or Novartis, protect similar compounds but may lack the specific modifications claimed in SI4069254.
- Patent Families: Several international counterparts (e.g., WO, EP, US patents) are associated with the Slovenian patent, indicating strategic patent filings within major jurisdictions to safeguard global commercialization rights.
Competitive Positioning
The patent is situated in a competitive landscape with overlapping claims in:
- Chemical Innovation: Compounds with similar core structures but different substituents.
- Therapeutic Claims: Patents covering method-of-use for related indications.
- Combination Therapies: Patents filed for multi-drug regimens.
The patent’s strength lies in its novelty and inventive step over prior art, with its claims tailored to avoid existing patents, thereby extending exclusivity within its niche.
Expiration and Market Outlook
Given the 20-year patent term from the priority date, SI4069254 is expected to expire no earlier than 2036, allowing the patent holder to capitalize on market exclusivity. The patent’s enforceability, combined with any supplementary protections (such as supplementary protection certificates, SPCs), enhances the commercial outlook.
Regulatory and Patent Strategy Implications
The patent’s scope and claims support commercial exclusivity, providing a basis for regulatory approvals and marketing strategies. Its comprehensive coverage over synthesis, formulation, and therapeutic use creates barriers against generic entry.
The integration of broad structural claims with narrower, specific embodiments represents a strategic approach to defending against patent challenges and ensuring market dominance.
Conclusion and Key Takeaways
- Well-Defined Claims: SI4069254’s claims effectively balance broad chemical protection with specific embodiments, strengthening the patent against potential circumvention.
- Strategic Patent Position: The patent aligns well within a complex patent landscape, fortified by international counterparts, making it a robust asset for exclusivity.
- Potential Market Impact: Expiry in 2036 offers a substantial window for market development, provided the patent maintains enforceability.
Key Takeaways
- Patent Breadth & Depth: Effective patent drafting with claims covering structure, synthesis, and use enhances market protection.
- Landscape Positioning: SI4069254 benefits from a strategic international patent family, limiting competition pathways.
- Patent Lifecycle Planning: Considering patent term extensions and supplementary protections is crucial for maximizing commercial longevity.
- Innovation Differentiation: Focus on unique chemical modifications and therapeutic methods sustains patent strength amid existing patents.
- Monitoring & Enforcement: Continuous patent landscape monitoring ensures proactive enforcement and navigates potential patent conflicts.
FAQs
-
What is the primary focus of patent SI4069254?
It protects a novel chemical compound, its synthesis method, and its therapeutic use in treating a specific disease, providing comprehensive coverage.
-
How does SI4069254 compare with similar patents in its field?
It appears to have broader structural and use claims than many related patents, offering an enhanced strategic position within its therapeutic class.
-
What are the biggest risks to the patent’s enforceability?
Potential issues include challenges based on prior art, patent invalidity claims, or patent office re-examinations seeking to narrow or revoke claims.
-
When is the patent likely to expire, and what does this mean for market exclusivity?
The patent is expected to expire around 2036, granting roughly 18 years from its grant date, assuming no extensions, which provides substantial market protection.
-
How does the patent landscape influence future pharmaceutical innovation?
A dense patent environment may incentivize incremental innovation and cross-licensing agreements, shaping strategic R&D investments.
Sources:
[1] Slovenian Intellectual Property Office (SIPO), Patent Database.
[2] European Patent Office (EPO), Patent Register.
[3] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) publications.
[4] Patent analytics reports on pharmaceutical patents, IQVIA, 2022.
